Pre-intervention SNOT-22 scores predict outcomes in aspirin exacerbated respiratory disease
Written By : Dr. Nandita Mohan
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2022-01-28 03:30 GMT | Update On 2022-01-28 03:30 GMT
Advertisement
Researchers have found in a new research that Preoperative SNOT-22 scores may be used as a predictor of postoperative, post-AD patient-reported outcomes in patient with aspirin exacerbated respiratory disease (AERD).
The results of the study have been published in the American Journal of Otolaryngology.
Edward C.Kuan and colleagues from the Department of Otolaryngology–Head and Neck Surgery, University of California, Irvine, CA, United States of America carried out this study to evaluate whether stratified preoperative, pre- aspirin desensitization (AD) sinonasal symptom scores predict postoperative, post-AD outcomes in Aspirin exacerbated respiratory disease (AERD).
The authors performed a retrospective chart review of a total of forty-seven patients, out of which 59.6% were female aged 48.0 ± 13.2 with aspirin challenge-proven AERD who underwent endoscopic sinus surgery followed by AD. Preoperative, postoperative/pre-AD, and postoperative/post-AD sinonasal symptom scores were collected (22-item Sino-Nasal Outcomes Test, SNOT-22).
Average time from surgery to AD was 70.0 ± 52.8 days. Preoperative SNOT-22 scores (n = 47) were divided into tertiles (cutoffs of 36 and 54 indicating mild [22.5 ± 13.7], moderate [44.3 ± 12.2], and severe [72.9 ± 19.7] disease). This corresponded to 12 (25.5%), 18 (38.3%), and 17 (36.2%) subjects being categorized into mild, moderate, and severe tertiles, respectively.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.